SERA Stock Analysis: Buy, Sell, or Hold?
SERA - Sera Prognostics, Inc. Class A Common Stock
$2.76
-0.04 (-1.43%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 18, 2026
Get Alerted When SERA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: SERA is down 14.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: SERA is down 14.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: SERA is currently trading at $2.76, which is considered oversold relative to its 30-day fair value range of $3.00 to $3.60.
Technical Outlook: Technically, SERA is showing sideways momentum. The price is currently testing key support at $2.76. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SERA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+78.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SERA is showing sideways momentum. The price is currently testing key support at $2.76. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SERA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+78.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$3.00 -
$3.60
Company Quality Score
52/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
60.4%
Protect Your Profits
Holding SERA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 78.6% below Wall St target ($5.00)
- WARNING: Recommendation downgraded due to -14.8% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$3.00 -
$3.60
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.28
(10.3%)
Support & Resistance Levels
Support Level
$2.76
Resistance Level
$3.69
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-4.00
Wall Street Target
$5.00
(+78.6%)
Revenue Growth (YoY)
-44.8%
Last updated: January 30, 2026 11:32 PM ET
Data refreshes hourly during market hours. Next update: 12:32 AM
Data refreshes hourly during market hours. Next update: 12:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SERA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
15
Sells
Net
INSIDERS SELLING
Recent Transactions
Robert Gardner Harrison
SELL
2000 shares
2025-10-07
Zhenya Lindgardt
SELL
3246 shares
2025-09-11
Robert Gardner Harrison
SELL
645 shares
2025-09-11
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$374 | 54 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced SERA Option Strategies
Professional options setups generated by AI based on today's SERA price and gamma walls.
